Using an ultra-high-resolution imaging technology called 7 Tesla functional MRI (fMRI) on human participants, researchers ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced robust lobe-specific changes in white ...

The European Medicines Agency (EMA) authorises initiation of a Phase IIa study evaluating AT-001 in patients diagnosed with Alzheimer's disease -- EMA grants Orphan Drug Designation (ODD) to AT-001 ...

Levels of iron in the brain could be a warning sign of future Alzheimer’s disease, a new study suggests. High levels of the chemical element have been shown to increase brain toxins and trigger ...

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL ...

The structural and functional organization of the brain as shown on MRI can predict the progression of brain atrophy in patients with early-stage, mild Parkinson's disease, according to a study ...

The European Medicines Agency (EMA) has granted approval to Iceland-based Arctic Therapeutics to commence a Phase IIa trial of small-molecule oral therapy, AT-001, targeting patients with Alzheimer’s ...

ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal ...

A long-term brain imaging study in aging adults showed faster rates of atrophy in certain brain structures to be associated with the risk of developing mild cognitive impairment (MCI). While some ...

For the first time, scientists have mapped the genetic architecture of the brain’s communication bridge—the corpus callosum—using AI and MRI data from over 50,000 people.